Detall de la convocatòria


Objectiu de la convocatòria
Funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program under the guidance of a scientific mentor.
Característiques principals
The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Applications in all areas of cancer research are accepted from U.S. and international applicants.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
• Carol Barnwell, Ext.: 1670
• Marta López, Ext.: 1576
Convocatòria (URL)
Application portal:
Applicants must meet the following criteria to qualify for a CDA:
  • Be a physician (MD, DO of international equivalent) working in any country.
  • Be in the first to third year of a full-time primary faculty appointment in a clinical department at an academic medical institution at the time of grant submission. Application must be submitted before the applicant has had three full years as faculty. Faculty appointment may begin with the entry-level faculty position within the applicant’s institution (i.e., Instructor/Lecturer, Assistant Professor, Assistant Member). 
  • Have a valid, active medical license in the country where the research will be conducted at the time of application.
  • Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research.
  • Be an ASCO member or have submitted a membership application with the grant application. Visit ASCO Membership to join/renew online.
  • Be able to commit at least 50% of full-time effort in research (applies to total research, not just the proposed project) during the award period.
  • Have a mentor from the sponsoring institution who must provide a letter of support. If the mentor is not an ASCO Member, a supporting letter from an ASCO Member from the sponsoring institution must be included.
  • Be up-to-date and in compliance with all requirements (e.g., progress reports, final reports, budget summaries, IRB approvals, etc.) of any past grants received from Conquer Cancer. Eligible applicants are allowed to hold only one active grant from Conquer Cancer at a time.
  • Applicants with concurrent federal career development awards (e.g., K23, K08, or any other type of career development award) and institutional KL2/K12 grants are eligible to apply provided there are no scientific and budgetary overlaps.
  • Applicants may not concurrently hold other career development awards from private foundations during the CDA-supported project term.
  • Past recipients of training fellowships (e.g., Young Investigator Award or an F32 grant) are eligible to apply.
  • Applicants should not have been a Principal Investigator on any large project grants (e.g., R01 or international equivalent).
  • Dotació
    3 years


    2024 CDA RFP as of 7.5.pdf